The following is a listing of recent articles about mesothelioma in medical journals that are available through PubMed, a search engine of the National Library of Medicine. The journal title, date, and page numbers follow the title, along with a link to PubMed.
- Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma.
Click here for abstract - High Dose Radiation Therapy Improves Survival in Patients with Mesothelioma.
Click here for abstract - Novel Complimentary Therapies Boost Role of Surgery for Mesothelioma Cancer.
Click here for abstract - Gene-modified PA1-STK cells home to tumor sites in patients with malignant pleural mesothelioma.
- Combined Resection, Intraperitoneal Chemotherapy and Whole Abdominal Radiation for the Treatment of Peritoneal Mesothelioma
- Phase I and Pharmacologic Study of Sequences of Gemcitabine and the Multitargeted Anifolate Agent in Patients With Advanced Solid Tumors
- Pleuropneumonectomy in the treatment of malignant pleural mesothelioma
Harrison LH Jr, Schwarzenberger PO, Byrne PS, Marrogi AJ, Kolls JK, McCarthy KE
Department of Surgery, Louisiana State University Health Sciences Center, New Orleans.
http://www.ncbi.nlm.nih.gov
Keohan ML, Chabot J, Fountain K, Antman KH, Taub RN
Columbia University Divisions of Medical Oncology (MLK, KHA, RNT), Surgery (JC), Radiation Oncology (KF), Columbia-Presbyterian Medical Center, New York, NY
http://www.cancer.med.umich.edu
Adjei AA, Erlichman C, Sloan JA, Reid JM, Pitot HC, Goldberg RM, Peethambaram P, Atherton P, Hanson LJ, Alberts SR, Jett J
Department of Oncology, Mayo Clinic and Foundation, Rochester, MN.
J Clin Oncol 2000 Apr. 8;18(8):1748-1757
http://www.ncbi.nlm.nih.gov
Grondin SC, Sugarbaker DJ
Division of Thoracic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Chest 1999 Dec;116(6 Suppl):450S-454S
Click here for the home page
Selected Press Releases
- Update on Phase III Program of ONCONASE ® for The Treatment of Patients with Unresectable Malignant Mesothelioma
Press Release from Alfacell, April 3, 2002 - Orphan Drug Designation Granted for Treatment of Mesothelioma and Ovarian Cancer
Press Release from NeoPharm, Inc., February 14, 2002 - Encouraging Survival in Patients With Advanced Malignant Mesothelioma Treated With Alfacell's ONCONASE ®
Press Release from Alfacell, Jan 22, 2002
Interviews With Mesothelioma Experts
Interviews with mesothelioma doctors, a patient, and an attorney to provide perspective on what mesothelioma is, how it's treated and what it's like to live with the disease. The following are transcripts of those interviews: Dr. Sugarbaker is a world-renowned expert in the diagnosis and treatment of pleural mesothelioma. In this interview, he gives specific information about the disease from initial symptoms to current therapy.
Belle was diagnosed with mesothelioma in October of 1998. Local doctors in Canada knew little about the disease. But she found hope and help through the Mesothelioma Resource Web that put her in touch with Boston's Dr. David Sugarbaker.
Dr. Perez-Soler is an extensively published and well-regarded medical professional with specialties in intermal medicine and medical oncology. He defines lung cancers and talks about the latest treatments.
Once someone is diagnosed with asbestos disease of any kind, legal questions often follow. Jonathan David, P.C.* is an attorney who has represented thousands of people with asbestos-related disease and mesothelioma. He discusses some of the medical and legal issues.
No comments:
Post a Comment